Sandra G. Adams, MD, MS

headshotAdamsBiographical Information:

Sandra G. Adams, MD, MS is a Professor of Medicine in the Pulmonary / Critical Care Division of The University of Texas Health Science Center at San Antonio (UTHSCSA) and Staff Physician at The South Texas Veterans Health Care System. Dr. Adams is an internationally recognized leader in Chronic Obstructive Pulmonary Disease (COPD) and the chronic care model. She has a strong interest and expertise in education and teaching.

Dr. Adams is a member of The Academy of Master Teachers, is recognized by the Chancellor of the University of Texas System as a Distinguished Teaching Professor and recently received the UTHSCSA Presidential Teaching Award. She was co-chair and co-developer of the interactive workshops delivered to primary care clinicians in 21 cities across the United States entitled “COPD: What Really Works? A Best Practices Workshop for Primary Care”, which resulted in significantly improved clinician self-confidence and knowledge as well as significant changes in clinical practice. She received her Masters of Science in Clinical Investigation degree in 2003.

Since that time, Dr. Adams has been actively involved in COPD research as a Principal Investigator and co-investigator for local, state and federally funded research projects. She is on the Executive Program committee and Vice-chair of the Simulation Committee of the American College of Chest Physicians (CHEST) and has recently been a member of the Education committee and on the Steering committee of the Airways NetWork for CHEST. Additionally, in 2010, Dr. Adams received the Distinguished Scholar Award from the Chest Foundation, which has provided resources to allow her to develop this Web-based Interactive Professional Education in COPD (WIPE COPD) program to educate primary care clinicians, respiratory therapists, pharmacists, nurses and medical assistants about COPD recognition, diagnosis and management:

Disclosure Information:

  • Investigator/Grant Research: Chest Foundation, National Institute of Health (NIH), Veterans Affairs Cooperative Studies Program, Bayer Pharmaceuticals Corp; Boehringer Ingelheim Pharmaceuticals, Inc; Centocor Inc, GlaxoSmithKline; Novartis Pharmaceuticals AG; Pfizer Inc; Schering-Plough Corp
  • Honoraria for Continuing Education (Unrestricted Grants for Continuing Education): AstraZeneca Pharmaceuticals LP; Bayer Pharmaceuticals Corp; Boehringer Ingelheim Pharmaceuticals, Inc; GlaxoSmithKline; Novartis Pharmaceuticals AG; Pfizer Inc; Schering-Plough Corp